|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||199.66 - 201.00|
|52-week range||166.56 - 240.96|
|Beta (5Y monthly)||1.37|
|PE ratio (TTM)||0.36|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
RESEARCH TRIANGLE PARK, N.C., September 26, 2023--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced it has appointed Richard Staub III, currently senior advisor to the Chairman and CEO, as president of its Research & Development Solutions (R&DS) business unit.
RESEARCH TRIANGLE PARK, N.C., September 12, 2023--IQVIA™ (NYSE:IQV), a global provider of data, analytics, technology solutions and services to the life sciences industry, has been named a Leader in the IDC Marketscape Worldwide Life Science R&D Pharmacovigilance Solutions 2022 Vendor Assessment.
RESEARCH TRIANGLE PARK, N.C., September 05, 2023--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Baird 2023 Global Healthcare Conference in New York City on Wednesday, September 13, 2023 at 10:50 a.m. ET.